Last reviewed · How we verify
Hyperbaric Oxygen Therapy
Hyperbaric Oxygen Therapy is a Small molecule drug developed by University of Arkansas. It is currently FDA-approved. Also known as: HBOT, Oxygen, Hyperbaric Oxygen.
At a glance
| Generic name | Hyperbaric Oxygen Therapy |
|---|---|
| Also known as | HBOT, Oxygen, Hyperbaric Oxygen |
| Sponsor | University of Arkansas |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study (PHASE4)
- Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions
- Adjunctive Hyperbaric Oxygen Treatment for Patients With Necrotizing Soft-Tissue Infection (HOT-NSTI Trial). Investigator-initiated, International, Multicentre, Superiority, Randomized, Open-label, Clinical Trial. (PHASE4)
- Hyperbaric Oxygen Therapy for Post Traumatic Stress Disorder - a Pragmatic, Double Blinded Randomized Trial (NA)
- Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments (NA)
- Optimal Number of Hyperbaric Oxygen Treatments for Carbon Monoxide Poisoning (NA)
- Self-hangIng Patient and Hyperbaric Oxygen Therapy _ SIPHON Study (PHASE4)
- The Effect of Nitrogen Narcosis on Motor Performance in Divers Who Have Sustained an Inner Ear Decompression Illness
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hyperbaric Oxygen Therapy CI brief — competitive landscape report
- Hyperbaric Oxygen Therapy updates RSS · CI watch RSS
- University of Arkansas portfolio CI
Frequently asked questions about Hyperbaric Oxygen Therapy
What is Hyperbaric Oxygen Therapy?
Hyperbaric Oxygen Therapy is a Small molecule drug developed by University of Arkansas.
Who makes Hyperbaric Oxygen Therapy?
Hyperbaric Oxygen Therapy is developed and marketed by University of Arkansas (see full University of Arkansas pipeline at /company/university-of-arkansas).
Is Hyperbaric Oxygen Therapy also known as anything else?
Hyperbaric Oxygen Therapy is also known as HBOT, Oxygen, Hyperbaric Oxygen.
What development phase is Hyperbaric Oxygen Therapy in?
Hyperbaric Oxygen Therapy is FDA-approved (marketed).
Related
- Manufacturer: University of Arkansas — full pipeline
- Also known as: HBOT, Oxygen, Hyperbaric Oxygen
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing